Skip to main content
. 2000 May;156(5):1581–1588. doi: 10.1016/S0002-9440(10)65030-4

Figure 5.

Figure 5.

Immunoblotting for EPO in endometriosis lesions and endometrium from endometriosis patients. Lanes 1 and 2: normal endometrium from two endometriosis patients, proliferative phase. Lanes 3 and 4: endometriosis tissue from proliferative phase. Only the endometriosis samples contained abundant EPO. Size markers were included. Reprobing of these blots for actin indicated equal loading of protein in all lanes.